Healthcare Intelligence
Pharma - Market Access & Commercialization
Real-time intelligence, expert analysis, and verified research for the Pharma - Market Access & Commercialization industry. Stay ahead in 3 minutes a day.
Stay ahead of Pharma - Market Access & Commercialization in 3 minutes a day.
Expert-verified intelligence delivered to your inbox every morning.
Free forever. No spam. Unsubscribe anytime.
Novo Nordisk's Wegovy wins Medicare coverage for heart disease
CMS approves Medicare coverage for Wegovy in cardiovascular disease, expanding access beyond weight loss indication.
Read full articleEli Lilly cuts Zepbound prices by 50% through new vial option
Lilly introduces single-dose vials at half the cost of auto-injectors to improve affordability and patient access.
Read full articleGSK launches patient assistance program for respiratory drugs
GSK expands access programs for asthma and COPD medications, offering free drugs to eligible uninsured patients.
Read full articleRoche partners with Amazon Pharmacy for cancer drug delivery
Strategic collaboration aims to improve patient access and adherence through streamlined specialty drug distribution.
Read full articleFDA approves first generic GLP-1 drug, disrupting market dynamics
Generic approval expected to significantly reduce costs and expand patient access to diabetes treatments.
Read full articlePfizer implements value-based contracts for new oncology portfolio
Outcomes-based pricing agreements with major payers tie reimbursement to real-world effectiveness data.
Read full articleJ&J expands copay assistance amid IRA pricing pressure
Johnson & Johnson increases patient support programs as Medicare negotiation impacts commercial pricing strategies.
Read full articleMerck launches digital platform for streamlined prior authorizations
AI-powered system reduces approval times from weeks to hours, improving patient access to specialty medications.
Read full articleNovo Nordisk's Wegovy wins Medicare coverage for heart disease
CMS approves Medicare coverage for Wegovy in cardiovascular disease, expanding access beyond weight loss indication.
Read full articleEli Lilly cuts Zepbound prices by 50% through new vial option
Lilly introduces single-dose vials at half the cost of auto-injectors to improve affordability and patient access.
Read full articleGSK launches patient assistance program for respiratory drugs
GSK expands access programs for asthma and COPD medications, offering free drugs to eligible uninsured patients.
Read full articleRoche partners with Amazon Pharmacy for cancer drug delivery
Strategic collaboration aims to improve patient access and adherence through streamlined specialty drug distribution.
Read full articleFDA approves first generic GLP-1 drug, disrupting market dynamics
Generic approval expected to significantly reduce costs and expand patient access to diabetes treatments.
Read full articlePfizer implements value-based contracts for new oncology portfolio
Outcomes-based pricing agreements with major payers tie reimbursement to real-world effectiveness data.
Read full articleJ&J expands copay assistance amid IRA pricing pressure
Johnson & Johnson increases patient support programs as Medicare negotiation impacts commercial pricing strategies.
Read full articleMerck launches digital platform for streamlined prior authorizations
AI-powered system reduces approval times from weeks to hours, improving patient access to specialty medications.
Read full articleStay ahead of Pharma - Market Access & Commercialization in 3 minutes a day.
Live opportunity intelligence for your market, delivered to your inbox every morning. Read it over coffee.
Free forever. No spam. Unsubscribe anytime.